EnnovaBio

CompanyChina

EnnovaBio develops one asset, in phase 2 (ENN0403 in diabetic macular edema). Mostly small molecule; based in China.

Assets
1
Furthest
Phase 2
Trials
1
Signals
0

Pipeline

1

  • ENN0403

    Phase 2Small moleculediabetic macular edema

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Trials1
  • Similar companies6

Updated 7 Oct 2026 · 2 sources

Intelligence